Free Trial

Asia summary

EQUITIES

Asian stocks were mixed overnight, on Covid cases and the effectiveness of Astarzeneca's vaccine.

  • The company reported that they will do an additional Global trial in an effort to clear the results of the last study.
  • Tokyo reported record covid cases, while China=Australia relations soured, after China announced that they will impose temporary anti-dumping measures on Australian Wine.
  • Asia indices traded heavy but have since recovered going into the early European session, to trade in green territory.
  • Nikkei 26,644.71
  • Shanghai 3,408.31
  • China A50 16,847.00
  • Hang Seng 26,977.45
  • Kospi 2,633.45

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.